Skip to main content

Advertisement

SpringerLink
Log in

A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples

  • Published:
The AAPS Journal Aims and scope Submit manuscript

Abstract

An overview is provided of the present population analysis methods and an assessment of which software packages are most appropriate for various PK/PD modeling problems. Four PK/PD example problems were solved using the programs NONMEM VI beta version, PDx-MCPEM, S-ADAPT, MONOLIX, and WinBUGS, informally assessed for reasonable accuracy and stability in analyzing these problems. Also, for each program we describe their general interface, ease of use, and abilities. We conclude with discussing which algorithms and software are most suitable for which types of PK/PD problems. NONMEM FO method is accurate and fast with 2-compartment models, if intra-individual and interindividual variances are small. The NONMEM FOCE method is slower than FO, but gives accurate population values regardless of size of intra- and interindividual errors. However, if data are very sparse, the NONMEM FOCE method can lead to inaccurate values, while the Laplace method can provide more accurate results. The exact EM methods (performed using S-ADAPT, PDx-MCPEM, and MONOLIX) have greater stability in analyzing complex PK/PD models, and can provide accurate results with sparse or rich data. MCPEM methods perform more slowly than NONMEM FOCE for simple models, but perform more quickly and stably than NONMEM FOCE for complex models. WinBUGS provides accurate assessments of the population parameters, standard errors and 95% confidence intervals for all examples. Like the MCPEM methods, WinBUGS's efficiency increases relative to NONMEM when solving the complex PK/PD models.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Csajka C, Verotta D. Pharmacokinetic-pharmacodynamic modelling: history and perspectives.J Pharmacokinet Pharmacodyn. 2006;33:227–279.

    Article  PubMed  CAS  Google Scholar 

  2. Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.J Pharmacokinet Biopharm. 1980;8:553–571.

    Article  PubMed  CAS  Google Scholar 

  3. Pillai G, Mentre F, Steimer JL. Non-linear mixed effects modeling—from methodology and software development to driving implementation in drug development science.J Pharmacokinet Pharmacodyn. 2005;32:161–183.

    Article  PubMed  CAS  Google Scholar 

  4. mandema JW. Population pharmacokinetics and pharmacodynamics. In: Welling PG, Tse FLS, eds.Pharmacokinetics. vol. 67. 2nd ed. New York, NY: Marcel Dekker, Inc.; 1995:411–450.

    Google Scholar 

  5. Roe DJ. Comparison of population pharmacokinetic modeling methods using simulated data: results from the population modeling workgroup.Stat Med. 1997;16:1241–1262.

    Article  PubMed  CAS  Google Scholar 

  6. Aarons L. Software for population pharmacokinetics and pharmacodynamics.Clin Pharmacokinet. 1999;36:255–264.

    Article  PubMed  CAS  Google Scholar 

  7. Mentre F, Mallet A, Steiner JL. Hyperparameter estimation using stochastic approximation with application to population. pharmacokinetics.Biometrics. 1988;44:673–683.

    Article  PubMed  CAS  Google Scholar 

  8. Bauer RJ, Guzy S. Monte Carlo parametric expectation maximization (MC-PEM) method for analyzing population pharmacokinetic/ pharmacodynamic data. In: D'Argenio DZ, ed.Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis. vol. 3. Boston, MA: Kluwer Academic Publishers; 2004:135–163.

    Chapter  Google Scholar 

  9. Best NG, Tan KK, Spiegelhalter DJ. Estimation of population pharmacokinetics using the Gibbs sampler.J Pharmacokinet Biopharm. 1995;23:407–435.

    Article  PubMed  CAS  Google Scholar 

  10. Lunn DJ, Best N, Thomas A, Wakefield J, Spiegelhalter D. Bayesian analysis of population PK/PD models: general concepts and software.J Pharmacokinet Pharmacodyn. 2002;29:271–307.

    Article  PubMed  CAS  Google Scholar 

  11. Beal SL, Sheiner LB.NONMEM Users Guide—Part VII. Hanover, MD: Globomax, Inc; 1992.

    Google Scholar 

  12. Users Guides NONMEM. [computer program]. Version V. Hanover, MD: Globomax, Inc; 1989–1998.

  13. PDx-MCPEM Users Guide [computer program]. Version 1.0. Hanover, MD: Globomax, Inc; 2006.

  14. S-ADAPT/MCPEM User's Guide [computer program]. Version 1.52. Berkeley, CA.; 2006.

  15. Monolix Users Manual [computer program]. Version 1.1. Orsay, France: Laboratoire de Mathematiques, U. Paris-Sud; 2005.

  16. PKBUGS software [computer program]. Version 2.0. Cambridge, UK: MRC Biostatistics Unit, 2006.

  17. Davidian M, Giltinan DM.Nonlinear Models for Repeated Measurement Data. New York, NY: Chapman and Hall, 1995.

    Google Scholar 

  18. Lindstrom ML, Bates DM. Nonlinear mixed effects models for repeated measures data.Biometrics. 1990;46:673–687.

    Article  PubMed  CAS  Google Scholar 

  19. Pinheiro JC, Bates DM. Approximations to the Log-likelihood function in the nonlinear mixed-effects model.J Comput Graph Statist. 1995;4:12–35.

    Article  Google Scholar 

  20. Beal SL, Sheiner LB. Estimating population kinetics.Crit Rev Biomed Eng. 1982;8:195–222.

    PubMed  CAS  Google Scholar 

  21. Ette EI, Kelman AW, Howie CA, Whiting B. Analysis of animal pharmacokinetic data: performance of the one point per animal design.J Pharmacokinet Biopharm. 1995;23:551–566.

    Article  PubMed  CAS  Google Scholar 

  22. Ette EI, Sun H, Ludden TM. Balanced designs in longitudinal population pharmacokinetic studies.J Clin Pharmacol. 1998;38:417–423.

    PubMed  CAS  Google Scholar 

  23. Jones CD, Sun H, Ette EI. Designing cross-sectional population pharmacokinetic studies: implications for pediatric and animal studies.Clin Res Pr Drug Regul Aff. 1996;13:133–165.

    Article  Google Scholar 

  24. White DB, Walawander CA, Tung Y, Grasela TH. An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis.J Pharmacokinet Biopharm. 1991;19:87–112.

    PubMed  CAS  Google Scholar 

  25. SAS online documentation, SAS/STAT Users Guide, NLMIXED procedure [computer program]. Version 8. Cary, NC: SAS Institute, Inc.; 2005.

  26. Jonsson S, Kjellsson MC, Karlsson MO. Estimating bias in population parameters for some models for repeated measures ordinals data using NONMEM and NLMIXED.J Pharmacokinet Pharmacodyn. 2004;31:299–320.

    Article  PubMed  CAS  Google Scholar 

  27. Schumitzky A. EM algorithms and two stage methods in pharmacokinetics population analysis. In: D'Argenio DZ, ed.Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis. vol. 2. Boston, MA: Kluwer Academic Publishers; 1995:145–160.

    Google Scholar 

  28. Mentre F, Gomeni R. A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics.J Biopharm Stat. 1995;5:141–158.

    Article  PubMed  CAS  Google Scholar 

  29. Walker S. An EM algorithm for nonlinear random effects models.Biometrics. 1996;52:934–944.

    Article  Google Scholar 

  30. Lavielle M. SAEM in MATLAB: an alternative to linearization (software presentation). Presented at: PAGE Meeting; June 17–18, 2004; Uppsala, Sweden. Uppsala, Sweden: Population Approach Group Europe; 2004: Abstract 544.

  31. Steimer JL, Mallet A, Golmard JL, Boisvieux JF. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model.Drug Metab Rev. 1984;15:265–292.

    Article  PubMed  CAS  Google Scholar 

  32. Lindstrom MJ, Bates DM. Newton-Raphson and EM algorithms for linear mixed-effects models for repeated-measures data.J Am Stat Assoc. 1988;83:1014–1022.

    Article  Google Scholar 

  33. Aarons L. The estimation of population pharmacokinetic parameters using an EM algorithm.Comput Methods Programs Biomed. 1993;41:9–16.

    Article  PubMed  CAS  Google Scholar 

  34. Thermo Kinetica software [computer program]. Version 4.4.1. Waltham, MA: Thermo Electron Corporation; 1997–2007.

  35. Gomeni R, Pineau G, Mentre F. Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package.Anticancer Res. 1994;14:2321–2326.

    PubMed  CAS  Google Scholar 

  36. Popkinetics software [computer program]. Version 1.0. University of Washington Seattle; 2006.

  37. Zhou Z, Rodman JH, Flynn PM, Robbins BL, Wilcox CK, D'Argenio DZ. Model for intracellular lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents.Antimicrob Agents Chemother. 2006;50:2686–2694.

    Article  PubMed  CAS  Google Scholar 

  38. Dokoumetzidis A, Aarons L. Propagation of population pharmacokinetic information using a Bayesian approach: comparison with meta-analysis.J Pharmacokinet Pharmacodyn. 2005;32:401–418.

    Article  PubMed  Google Scholar 

  39. Gilks WR. Full conditional distributions. In: Gilks WR, Richardson S, Spiegelhalter DJ, eds.Markov Chain Monte Carlo in Practice. New York, NY: Chapman and Hall; 1996:75–88.

    Google Scholar 

  40. Gilks WR, Richardson S, Spiegelhalter DJ. Introducing Markov chain Monte Carlo. In: Gilks WR, Richardson S, Spiegelhalter DJ, eds.Markov Chain Monte Carlo in Practice. New York, NY: Chapman and Hall; 1996:1–19.

    Google Scholar 

  41. Bennett JE, Racine-Poon A, Wakefield AJ. MCMC for nonlinear heirarchical models. In: Gilks WR, Richardson S, Spiegelhalter DJ, eds.Markov Chain Monte Carlo in Practice. New York, NY: Chapman and Hall; 1996:339–357.

    Google Scholar 

  42. Gueroguieva I, Aarons L, Rowland M. Diazepam pharmacokinetics from preclinical to Phase 1 using a Bayesian population physiologically based pharmacokinetics model with informative prior distributions in Winbugs.J Pharmacokinet Pharmacodyn. 2006;33:1–24.

    Article  Google Scholar 

  43. ADAPT II Users Guide. Pharmacokinetic/Pharmacodynamic Systems Analysis Software. [computer program]. Version (Release) 4. Los Angeles, CA: Biomedical Simulations Resource, University of Southern California; 1997.

    Google Scholar 

  44. Ng CM, Joshi A, Dedrick R, Garovoy M, Bauer R. Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis.Pharm Res. 2005;22:1088–1100.

    Article  PubMed  CAS  Google Scholar 

  45. Mu S, Ludden TM. Estimation of population pharmacokinetic parameters in the presence of non-compliance.J Pharmacokinet Pharmacodyn. 2003;30:53–81.

    Article  PubMed  Google Scholar 

  46. Duffull SB, Kirkpatrick CJ, Green B, Holford NH. Analysis of population pharmcokinetic data using NONMEM and Winbugs.J Biopharm Stat. 2005;15:53–73.

    Article  PubMed  Google Scholar 

  47. Girard P, Mentre F. A comparison of estimation methods in nonlinear mixed effects models using a blind analysis. Presented at: PAGE Meeting; June 16–17, 2005; Pamplona, Spain. Population Approach Group Europe; 2005: Abstract 834.

Download references

Author information

Authors and Affiliations

  1. Pharmacokinetics, Pharmacodynamics, and Bioinformatics, XOMA (US) LLC, 2910 Seventh Street, 94710, Berkeley, CA

    Robert J. Bauer & Serge Guzy

  2. Institute for Drug Development/Cancer Research and Therapy Center, San Antonio, TX

    Chee Ng

Authors
  1. Robert J. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serge Guzy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chee Ng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert J. Bauer.

Additional information

Published: March 2, 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bauer, R.J., Guzy, S. & Ng, C. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples. AAPS J 9, 7 (2007). https://doi.org/10.1208/aapsj0901007

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/aapsj0901007

Keywords

Search

Navigation